Adenosine-mediated activation of A(2A)R drives immunosuppressive signaling in high-adenosine tumor microenvironments (TMEs), impeding anticancer immunity. Targeting A(2A)R with negative allosteric modulators (NAMs) is a promising approach for cancer immunotherapy: unlike the orthosteric antagonists currently in use, which face competitive and off-target limitations, NAMs leverage a noncompetitive, saturable mechanism that enhances receptor selectivity. The development of a novel series of A(2A)R NAMs demonstrates potent activity within high-adenosine TMEs, underscoring a significant translational potential in oncology.

Negative Allosteric Modulators of A2AR: A New Weapon for Cancer Immunotherapy? / Zambon, A.. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 68:4(2025), pp. 4053-4055. [10.1021/acs.jmedchem.5c00137]

Negative Allosteric Modulators of A2AR: A New Weapon for Cancer Immunotherapy?

Zambon A.
2025

Abstract

Adenosine-mediated activation of A(2A)R drives immunosuppressive signaling in high-adenosine tumor microenvironments (TMEs), impeding anticancer immunity. Targeting A(2A)R with negative allosteric modulators (NAMs) is a promising approach for cancer immunotherapy: unlike the orthosteric antagonists currently in use, which face competitive and off-target limitations, NAMs leverage a noncompetitive, saturable mechanism that enhances receptor selectivity. The development of a novel series of A(2A)R NAMs demonstrates potent activity within high-adenosine TMEs, underscoring a significant translational potential in oncology.
2025
68
4
4053
4055
Negative Allosteric Modulators of A2AR: A New Weapon for Cancer Immunotherapy? / Zambon, A.. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - 68:4(2025), pp. 4053-4055. [10.1021/acs.jmedchem.5c00137]
Zambon, A.
File in questo prodotto:
File Dimensione Formato  
zambon-2025-negative-allosteric-modulators-of-a2ar-a-new-weapon-for-cancer-immunotherapy.pdf

Open access

Tipologia: VOR - Versione pubblicata dall'editore
Dimensione 1.03 MB
Formato Adobe PDF
1.03 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1373993
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact